Techniques based on fluorescence in situ hybridization (FISH) have bridged
the gap between molecular genetics and conventional cytogenetics. Since its
introduction in the late 1980s, advanced FISH-based methods have greatly e
nhanced the cytogenetic analysis of hematopoietic and solid tumors and are
rapidly gaining ground in clinical cytogenetic diagnostics. As interest in
FISH technologies has grown, it has inspired an era of new FISH-based techn
ologies such as multiplex FISH, spectral karyotyping, and comparative genom
ic hybridization, In this review, the focus is on the impact of these techn
ologies in the field of cancer genetics. (C) 2000 Lippincott Williams & Wil
kins, Inc.